Quest’s genomic sequencing and infectious disease expertise will identify novel SARS-CoV-2 mutations, providing insights on prevalence and transmission in the United States SECAUCUS, N.J., Jan. 18...read more
Latest news and articles
Leading Biopharmaceutical Companies Select Invitae to Develop Standardized Panel to Detect Molecular Residual Disease (MRD) in Patients with Acute Myeloid Leukemia (AML)
Project aims to standardize MRD data generation, assessment and accelerate AML clinical trial programs bringing novel therapies to patients in need faster SAN FRANCISCO, Jan. 14, 2021 /PRNewswire/ — Invitae...read more
Pacific Biosciences and Invitae to Develop Ultra-High-Throughput Clinical Whole Genome Sequencing Platform
New platform expected to make whole genome sequencing significantly more affordable and accessible for use in mainstream medical care MENLO PARK, Calif., Jan. 13, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of...read more
The Promise and Hope of RNA-based vaccines for COVID-19
The worldwide devastation wrought by the COVID-19 pandemic is well known to everyone, as is the resulting push to develop effective vaccines and therapies that have been proceeding on a massive scale and at rapid pace...read more
Broad Institute and Verily partner with Microsoft to accelerate the next generation of the Terra platform for health and life science research
Multiyear partnership brings together advanced technology, industry expertise and scale to help researchers interpret an unprecedented amount of biomedical data and derive insights to advance the treatment of human...read more
NuProbe Closes $42M Fundraising
HOUSTON and SHANGHAI, Jan. 11, 2021 /PRNewswire/ — NuProbe, a genomics and molecular diagnostics company specialized in ultrasensitive sequencing panels, announces the closing of its oversubscribed $42M fundraising. The...read more
QIAGEN Announces Global Distribution Agreement for the COSMIC Database from the Wellcome Sanger Institute
Exclusive sales, marketing, support and distribution by QIAGEN Including over 71 million cancer mutations, the COSMIC Database joins QIAGENs’ portfolio for cancer genomic analysis and interpretation Agreement effective...read more
Illumina and Helix Collaborate to Assess Prevalence of New SARS-CoV-2 UK Variant (B.1.1.7) in the US and Develop National Surveillance Infrastructure
With support from the Centers for Disease Control and Prevention (CDC), Illumina and Helix have already identified more than 50 cases of the new variant in the US SAN DIEGO–(BUSINESS WIRE)– Illumina, Inc...read more
2020 Was Not Just About COVID-19
Certainly, the coronavirus and, with that COVID-19, has dominated 2020 and massively impacted not only our daily lives, but also the medical health care community and healthcare facilities in particular. Genomics proved...read more
Singlera Genomics raises $150 million in Series B financing to promote the development and commercialization of early cancer screening products
SAN DIEGO and SHANGHAI, Dec. 15, 2020 /PRNewswire/ — Singlera Genomics Inc. today announced that it raised $150 million in Series B financing. This round of financing was...read more
